Teva, Allergan Settle Opioid MDL Bellwether Case For $54M Cash, $20M In Narcan

Mealey's (July 13, 2022, 1:57 PM EDT) -- SAN FRANCISCO — Opioid manufacturers Teva Pharmaceuticals USA Inc. and Allergan PLC have agreed to settle a multidistrict bellwether trial with San Francisco for $54 million in cash and 10 years’...
To view the full article, register now.